Journal
CELL PROLIFERATION
Volume 52, Issue 3, Pages -Publisher
WILEY
DOI: 10.1111/cpr.12605
Keywords
FGF; FGFR; pancreatic cancer; target; therapy
Categories
Funding
- National Natural Science Foundation of China [81572936, 81773186]
Ask authors/readers for more resources
Recently, fibroblast growth factors are identified to play a vital role in the development and progression of human pancreatic cancer. FGF pathway is critical involved in numerous cellular processes through regulation of its downstream targets, including proliferation, apoptosis, migration, invasion, angiogenesis and metastasis. In this review article, we describe recent advances of FGFR signalling pathway in pancreatic carcinogenesis and progression. Moreover, we highlight the available chemical inhibitors of FGFR pathway for potential treatment of pancreatic cancer. Furthermore, we discuss whether targeting FGFR pathway is a novel therapeutic strategy for pancreatic cancer clinical management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available